Niger vs South-East Asia (WHO region): Number of malaria positive cases by rapid diagnostic test
Niger
6.90 million
in 2024
South-East Asia (WHO region)
266,650
in 2021
Niger rank
9th
South-East Asia (WHO region) rank
8th
Number of malaria positive cases by rapid diagnostic test over time
- Niger
- South-East Asia (WHO region)
How they compare
Niger currently reports 6.90 million against 266,650 in South-East Asia (WHO region), a difference of 6.63 million.
That makes Niger's figure about 25.9 times South-East Asia (WHO region)'s.
Across all 7 years both countries report, Niger has been ahead every year.
Niger ranks 9th and South-East Asia (WHO region) ranks 8th of 86 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.69 million | 327,475 | 2.36 million | Niger |
| 2020s | 4.00 million | 257,047 | 3.74 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of malaria positive cases by rapid diagnostic test, Niger or South-East Asia (WHO region)?
- Niger, at 6.90 million against 266,650 in South-East Asia (WHO region) as of 2024.
- What is the difference in number of malaria positive cases by rapid diagnostic test between Niger and South-East Asia (WHO region)?
- 6.63 million, with Niger ahead.
- How many years of comparable data are there for Niger and South-East Asia (WHO region)?
- 7 years are reported by both, from 2015 to 2021.
- How do Niger and South-East Asia (WHO region) rank globally for number of malaria positive cases by rapid diagnostic test?
- Niger ranks 9th and South-East Asia (WHO region) ranks 8th of 86 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of malaria positive cases by rapid diagnostic test (RDT). Statizoid refreshes it automatically from the source and publishes the full history for both places.